Iohexol |
|
Katalog-Nr.GC16105
|
Iohexol ist ein RÖntgenkontrastmittel und kann in vivo fÜr Myelographie, Computertomographie (Zisternographie, Ventrikulographie) und MicroCT-Bildgebung angewendet werden.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 66108-95-0
Sample solution is provided at 25 µL, 10mM.
Iohexol, a low osmolality nonionic contrast media, is a tri-iodinated benzene derivative with a molecular weight of 821.1Da[1]. Iohexol is used as a marker of glomerular filtration rate (GFR) and as an alternative to radiotracer[2].
In vitro, Iohexol treatment for 72 hours significantly inhibited the viability of CC-531 and AML12 cells, with IC50 values of 46.6mM and 26.8mM, respectively[3]. Treatment of HK-2 cells with 100mgI/ml Iohexol for 24 hours significantly induced apoptosis, mitochondrial damage, and significantly inhibited cell migration[4]. Treatment of NRK 52-E cells with 150mgI/ml Iohexol for 12 hours resulted in massive cell death, resulting in numerous round vacuoles in the cytoplasm[5].
In vivo, Iohexol treatment via single dose injection of 5μl (300mg/mL) into the left paw of mice for 15 minutes increased paw thickness and swelling, inducing a local anaphylactogenic reaction in mice[6]. Intraperitoneal injection of a single dose of Iohexol (3gI/kg) for 24h resulted in renal lesions in C57BL/6 mice, with vacuolization of the renal cortex and induction of proximal tubular inflammation[7].
References:
[1] Seegmiller J C, Eckfeldt J H, Lieske J C. Challenges in measuring glomerular filtration rate: a clinical laboratory perspective[J]. Advances in chronic kidney disease, 2018, 25(1): 84-92.
[2] Brown S C W, O’reilly P H. Iohexol clearance for the determination of glomerular filtration rate in clinical practice: evidence for a new gold standard[J]. The Journal of urology, 1991, 146(3): 675-679.
[3] Melancon M P, Yevich S, Avritscher R, et al. A novel irinotecan-lipiodol nanoemulsion for intravascular administration: pharmacokinetics and biodistribution in the normal and tumor bearing rat liver[J]. Drug delivery, 2021, 28(1): 240-251.
[4] Xiao-Yan G O U, Yong L I, Xiao-Ping F A N. The Role of Mdivi-1 in Reducing Mitochondrial Fission via the NF-κB/JNK/SIRT3 Signaling Pathway in Acute Kidney Injury[J]. Physiological Research, 2025, 74(1): 79.
[5] Jensen H, Doughty R W, Grant D, et al. The effects of the iodinated X-ray contrast media iodixanol, iohexol, iopromide, and ioversol on the rat kidney epithelial cell line NRK 52-E[J]. Renal failure, 2011, 33(4): 426-433.
[6] Yuan F, Zhang C, Sun M, et al. MRGPRX2 mediates immediate-type pseudo-allergic reactions induced by iodine-containing iohexol[J]. Biomedicine & Pharmacotherapy, 2021, 137: 111323.
[7] Lee H T, Jan M, Bae S C, et al. A1 adenosine receptor knockout mice are protected against acute radiocontrast nephropathy in vivo[J]. American Journal of Physiology-Renal Physiology, 2006, 290(6): F1367-F1375.
Dynamic Contrast Enhanced Micro-CT Angiography Protocol
1. Pre-experiment Preparation
(1) Weigh BALB/c mice (8-12 weeks old), and calculate the Iohexol dose: 25µl/g (=7.5mgI/g).
(2) Prepare the anesthetic mixture, sterilize with a 0.2µm filter, store the mixture in the dark at 4°C, and use immediately after preparation.
(3) 5ml of Iohexol (300mgI/ml) is added to 5ml of sterile saline and mixed to obtain 10ml of 150mI/ml working solution, sterilized with a 0.2µm filter, stored in the dark, and used immediately after preparation.
(4) Draw Iohexol into a 1ml syringe, expel air bubbles, and attach Iohexol to the injection pump. Set the flow rate: total injection volume (µl) = 25µl × body weight (g). Injection time = 45s → flow rate (µl/s) = total volume/45.
(5) Fix the mouse on a heating pad (37°C), and monitor the rectal temperature in real time to maintain it at 36.5-37.5°C.
2. Intravenous Injection
(1) Wipe the mouse tail's posterior 1/3 with an alcohol swab, and use an infrared lamp to assist in dilating the tail vein.
(2) Insert the indwelling needle, confirm the return of blood, and fix; connect the other end of the catheter to the injection pump extension tube filled with Iohexol.
(3) Slowly inject 20µl of 0.9% NaCl to verify that the channel is unobstructed without leakage.
3. Dynamic Contrast Scanning Procedure
(1) First, collect the "pre-contrast" baseline sequence (example parameters: 80kV; 500µA; 360-degree projection; 10min).
(2) Start the scan and trigger the injection pump simultaneously; immediately begin the first round of "post-contrast" scan after the injection is completed (45s).
(3) Repeat the post-contrast scan every 50s for a total of 5 periods; the entire process takes approximately 4.5min.
(4) After the scan, slowly remove the needle, apply local pressure to stop bleeding for 30s; place the mice on the heating pad to recover, and return the mice to the cage once the righting reflex returns.
4. Postoperative Observation
(1) Observe breathing, skin color, and activity at 0, 30, and 60min, record any adverse reactions (convulsions, respiratory depression, etc.).
(2) Provide 5% glucose water within 24h to aid iodine excretion.
(3) If multiple contrast scans are needed, the interval should be ≥ 72h, and monitor serum creatinine to assess renal function.
5. Precautions
(1) Iohexol is a low-osmolar non-ionic contrast agent and can be stored at room temperature; check for crystallization before use, and if present, dissolve Iohexol in a 37°C water bath.
(2) The depth of anesthesia should be such that there is no withdrawal reflex when the toe is pinched; too deep anesthesia can cause respiratory depression, and too shallow can result in motion artifacts.
(3) If the experimental period is > 1h, administer 0.3ml of warm saline intraperitoneally every 20min to prevent dehydration and hypotension.
References:
[1] Yan D, Zhang Z, Luo Q, et al. A novel mouse segmentation method based on dynamic contrast enhanced micro-CT images[J]. PLoS One, 2017, 12(1): e0169424.
| Cas No. | 66108-95-0 | SDF | |
| Chemical Name | (1Z,3Z)-N'1,N'3-bis(2,3-dihydroxypropyl)-5-(N-(2,3-dihydroxypropyl)acetamido)-2,4,6-triiodoisophthalimidic acid | ||
| Canonical SMILES | CC(N(C1=C(I)C(/C(O)=N/CC(O)CO)=C(I)C(/C(O)=N/CC(O)CO)=C1I)CC(O)CO)=O | ||
| Formula | C19H26I3N3O9 | M.Wt | 821.14 |
| Löslichkeit | ≥ 31.85mg/mL in DMSO | Storage | 4°C, protect from light |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 1.2178 mL | 6.0891 mL | 12.1782 mL |
| 5 mM | 243.6 μL | 1.2178 mL | 2.4356 mL |
| 10 mM | 121.8 μL | 608.9 μL | 1.2178 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL saline, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >98.00% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 1 reference(s) in Google Scholar.)















